---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-112845"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2026-10-01T20:30:27+00:00"
generated_at: "2026-10-12T14:25:02.618893+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech repays final $15M Oaktree debt, terminates $50M secured credit facility

## Summary
- On September 30, 2026 repaid $15.0M remaining principal under the Oaktree senior secured credit agreement, plus ~$435,000 accrued interest and a $150,000 prepayment fee.
- All liens and security interests in Company property were released and terminated; the Oaktree Agreement automatically terminated per its terms.
- Original $50.0M facility with Oaktree Fund Administration, LLC was entered July 25, 2024 and amended December 12, 2025 and February 22, 2026.
- Repayment clears all remaining indebtedness under the facility, leaving the company with no obligations to the Oaktree lenders.
- 8-K signed by CFO David Jin and dated October 1, 2026; no new guidance or financial results provided.

## SEC filing metadata
- accession: 0001104659-26-112845
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2026-10-01T20:30:27+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000110465926112845/0001104659-26-112845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000110465926112845/fbio-20260930x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-112845
- JSON: https://secwatch.observer/filing/0001104659-26-112845.json
- Plain text: https://secwatch.observer/filing/0001104659-26-112845.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
